高维毅, 何锡尧, 宋青雯, 李明美, 陈碧兰. M-P-R型磷酰胺类抗肿瘤化合物的合成J. 药学学报, 1965, 12(10): 672-677.
引用本文: 高维毅, 何锡尧, 宋青雯, 李明美, 陈碧兰. M-P-R型磷酰胺类抗肿瘤化合物的合成J. 药学学报, 1965, 12(10): 672-677.
KAO WEI-I HO HSI-YAO SONC CHING-WEN LI MING-MEI CHENG BEE-LAN, . TUMOUR CHEMOTHERAPY:SYNTHESES OF N-PHOSPHORYLATED NITROGEN MUSTARDS AND RELATED COMPOUNDSJ. Acta Pharmaceutica Sinica, 1965, 12(10): 672-677.
Citation: KAO WEI-I HO HSI-YAO SONC CHING-WEN LI MING-MEI CHENG BEE-LAN, . TUMOUR CHEMOTHERAPY:SYNTHESES OF N-PHOSPHORYLATED NITROGEN MUSTARDS AND RELATED COMPOUNDSJ. Acta Pharmaceutica Sinica, 1965, 12(10): 672-677.

M-P-R型磷酰胺类抗肿瘤化合物的合成

TUMOUR CHEMOTHERAPY:SYNTHESES OF N-PHOSPHORYLATED NITROGEN MUSTARDS AND RELATED COMPOUNDS

  • 摘要: 本文叙述了二十三个磷酰胺和磷酰胺酯化合物的合成,以研究其抗肿瘤活性。合成的化合物部分经过了动物筛选。化合物II、III、VII、VIII和XXII对小鼠肉瘤180有明显抑制作用。化合物1对多种动物肿瘤具有显著活性,并已推荐临床试用。

     

    Abstract: Since phosphamidases are more abundant in neoplastic tissue than normal tissue, twenty-three N-phosphorylated nitrogen mustards and ethylenephosphoramides were prepared in order to find anticancer agents with more selectivity against the malignant tumours. The compounds synthesized were listed in the Chinese text in Table 1. Preliminary pharmacological tests have revealed that the compounds (II, III, VII, VIII, and XXII) have remarkable inhibitory action against Sarcoma 180 in mice, and compound (I) possesses pronounced inhibitory activity against Yoshida Ascites sarcoma and several other animal tumours. The last one is now under clinical trials.

     

/

返回文章
返回